317 related articles for article (PubMed ID: 7898661)
41. Vascularization and microvascular permeability in solid versus cell-suspension embryonic neural grafts.
Leigh K; Elisevich K; Rogers KA
J Neurosurg; 1994 Aug; 81(2):272-83. PubMed ID: 7517998
[TBL] [Abstract][Full Text] [Related]
42. Differential effects of platelet-derived growth factor isoforms on dopamine neurons in vivo: -BB supports cell survival, -AA enhances fiber formation.
Giacobini MM; Almström S; Funa K; Olson L
Neuroscience; 1993 Dec; 57(4):923-9. PubMed ID: 7906018
[TBL] [Abstract][Full Text] [Related]
43. Sequential intrastriatal grafting of allogeneic embryonic dopamine-rich neuronal tissue in adult rats: will the second graft be rejected?
Duan WM; Widner H; Björklund A; Brundin P
Neuroscience; 1993 Nov; 57(2):261-74. PubMed ID: 7906872
[TBL] [Abstract][Full Text] [Related]
44. Astrocytes and extracellular matrix following intracerebral transplantation of embryonic ventral mesencephalon or lateral ganglionic eminence.
Gates MA; Laywell ED; Fillmore H; Steindler DA
Neuroscience; 1996 Sep; 74(2):579-97. PubMed ID: 8865207
[TBL] [Abstract][Full Text] [Related]
45. The effect of L-dopa and carbidopa treatment on the survival of rat fetal dopamine grafts assessed by tyrosine hydroxylase immunohistochemistry and [3H]mazindol autoradiography.
Blunt SB; Jenner P; Marsden CD
Neuroscience; 1991; 43(1):95-110. PubMed ID: 1681462
[TBL] [Abstract][Full Text] [Related]
46. Functional improvement with low-dose dopaminergic grafts in hemiparkinsonian rats.
Bartlett LE; Sadi D; Lewington M; Mendez I
Neurosurgery; 2004 Aug; 55(2):405-12; discussion 412-5. PubMed ID: 15271249
[TBL] [Abstract][Full Text] [Related]
47. Effects of graft pooling of foetal rat and mouse tissue and immunosuppression in the 6-hydroxydopamine rat model of Parkinson's disease.
Schwarz SC; Sauer H; Oertel WH; Earl CD; Kupsch AR
Exp Brain Res; 1997 Jun; 115(1):71-82. PubMed ID: 9224835
[TBL] [Abstract][Full Text] [Related]
48. Expression of BDNF and trkB mRNAs in comparison to dopamine D1 and D2 receptor mRNAs and tyrosine hydroxylase-immunoreactivity in nigrostriatal in oculo co-grafts.
Strömberg I; Humpel C
Brain Res Dev Brain Res; 1995 Feb; 84(2):215-24. PubMed ID: 7743642
[TBL] [Abstract][Full Text] [Related]
49. A novel strategy for intrastriatal dopaminergic cell transplantation: sequential "nest" grafting influences survival and behavioral recovery in a rat model of Parkinson's disease.
Timmer M; Nikkhah G
Exp Cell Res; 2012 Dec; 318(20):2531-42. PubMed ID: 23010385
[TBL] [Abstract][Full Text] [Related]
50. Addition of fresh blood to intrastriatal grafts of embryonic mesencephalon into the hemiparkinsonian rat does not impair the survival of grafted dopaminergic neurones.
Zietlow R; Dunnett SB; Fawcett JW
Exp Neurol; 1999 Mar; 156(1):205-8. PubMed ID: 10192791
[TBL] [Abstract][Full Text] [Related]
51. Diminished survival of mesencephalic dopamine neurons grafted into aged hosts occurs during the immediate postgrafting interval.
Sortwell CE; Camargo MD; Pitzer MR; Gyawali S; Collier TJ
Exp Neurol; 2001 May; 169(1):23-9. PubMed ID: 11312554
[TBL] [Abstract][Full Text] [Related]
52. Fibroblast growth factors enhance dopamine fiber formation from nigral grafts.
Giacobini MM; Strömberg I; Almström S; Cao Y; Olson L
Brain Res Dev Brain Res; 1993 Sep; 75(1):65-73. PubMed ID: 7693370
[TBL] [Abstract][Full Text] [Related]
53. Preservation of fetal ventral mesencephalic cells by cool storage: in-vitro viability and TH-positive neuron survival after microtransplantation to the striatum.
Nikkhah G; Eberhard J; Olsson M; Björklund A
Brain Res; 1995 Jul; 687(1-2):22-34. PubMed ID: 7583311
[TBL] [Abstract][Full Text] [Related]
54. Fetal dopamine cell survival after transplantation is dramatically improved at a critical donor gestational age in nonhuman primates.
Sladek JR; Elsworth JD; Roth RH; Evans LE; Collier TJ; Cooper SJ; Taylor JR; Redmond DE
Exp Neurol; 1993 Jul; 122(1):16-27. PubMed ID: 8101820
[TBL] [Abstract][Full Text] [Related]
55. Implantation of bioactive growth factor-secreting rods enhances fetal dopaminergic graft survival, outgrowth density, and functional recovery in a rat model of Parkinson's disease.
Törnqvist N; Björklund L; Almqvist P; Wahlberg L; Strömberg I
Exp Neurol; 2000 Jul; 164(1):130-8. PubMed ID: 10877923
[TBL] [Abstract][Full Text] [Related]
56. Ultrastructural analysis of graft-to-host connections, with special reference to dopamine-neuropeptide Y interactions in the rat striatum, after transplantation of fetal mesencephalon cells.
Vuillet J; Moukhles H; Nieoullon A; Daszuta A
Exp Brain Res; 1994; 98(1):84-96. PubMed ID: 7912201
[TBL] [Abstract][Full Text] [Related]
57. Cryopreservation, survival and function of intrastriatal fetal mesencephalic grafts in a rat model of Parkinson's disease.
Sauer H; Frodl EM; Kupsch A; ten Bruggencate G; Oertel WH
Exp Brain Res; 1992; 90(1):54-62. PubMed ID: 1355744
[TBL] [Abstract][Full Text] [Related]
58. Platelet-derived growth factor receptor expression after neural grafting in a rat model of Parkinson's disease.
Ballagi AE; Odin P; Othberg-Cederström A; Smits A; Duan WM; Lindvall O; Funa K
Cell Transplant; 1994; 3(6):453-60. PubMed ID: 7881757
[TBL] [Abstract][Full Text] [Related]
59. Comparison of embryonic stem cell-derived dopamine neuron grafts and fetal ventral mesencephalic tissue grafts: morphology and function.
Yurek DM; Fletcher-Turner A
Cell Transplant; 2004; 13(3):295-306. PubMed ID: 15191167
[TBL] [Abstract][Full Text] [Related]
60. Comparison between normal developing striatum and developing striatal grafts using drug-induced Fos expression and neuron-specific enolase immunohistochemistry.
Labandeira-Garcia JL; Tobio JP; Guerra MJ
Neuroscience; 1994 May; 60(2):399-415. PubMed ID: 7915411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
